Prelude Therapeutics Inc. (PRLD): Price and Financial Metrics
GET POWR RATINGS... FREE!
PRLD Stock Price Chart Interactive Chart >
PRLD Price/Volume Stats
| Current price | $5.52 | 52-week high | $43.55 |
| Prev. close | $5.15 | 52-week low | $3.87 |
| Day low | $5.20 | Volume | 106,500 |
| Day high | $5.79 | Avg. volume | 264,169 |
| 50-day MA | $4.71 | Dividend yield | N/A |
| 200-day MA | $11.21 | Market Cap | 263.28M |
Prelude Therapeutics Inc. (PRLD) Company Bio
Prelude Therapeutics, Inc. operates as a cancer drug discovery company. It focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Gopi Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Latest PRLD News From Around the Web
Below are the latest news stories about Prelude Therapeutics Inc that investors may wish to consider to help them evaluate PRLD as an investment opportunity.
Prelude Therapeutics to Present at the H.C. Wainwright BioConnect Virtual ConferenceWILMINGTON, Del., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Prelude Therapeutics Inc. (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that Kris Vaddi, PhD, Chief Executive Officer, will present at the H.C Wainwright BioConnect Virtual Conference, being held on January 10-13, 2022. The prerecorded presentation will become available on Monday, January 10, 2022 at 7:00 am ET and can be accessed by visiting the “Investors” page under the “Events & Presentation” section of the Pr |
Orbimed Advisors Llc Buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, ...New York, NY, based Investment company Orbimed Advisors Llc (Current Portfolio) buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, HCA Healthcare Inc, Erasca Inc, sells Prelude Therapeutics Inc, Aurinia Pharmaceuticals Inc, Ascendis Pharma A/S, Natera Inc, Anthem Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Orbimed Advisors Llc. |
The 10 Most Shorted Stocks Right Now for Friday, Dec. 17Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we're diving into some top candidates! |
In spite of Prelude Therapeutics Incorporated's recent pullback, insiders still gained about US$12k after buying earlier this year.Insiders who bought Prelude Therapeutics Incorporated ( NASDAQ:PRLD ) stock lover the last 12 months are probably not... |
Prelude Therapeutics Inc (PRLD) EVP, Head of Chemistry Andrew Combs Bought $94,880 of SharesEVP, Head of Chemistry of Prelude Therapeutics Inc (30-Year Financial, Insider Trades) Andrew Combs (insider trades) bought 8,000 shares of PRLD on 12/14/2021 at an average price of $11.86 a share. |
PRLD Price Returns
| 1-mo | 15.48% |
| 3-mo | -16.11% |
| 6-mo | -45.07% |
| 1-year | -79.33% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -55.66% |
| 2021 | -82.60% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...